JIUYUAN GENE Appoints Dr. Huang Wenli as Independent Non-Executive Director
Stock News
Jun 15
The board of JIUYUAN GENE (02566) has announced that Dr. Huang Wenli has been elected as an independent non-executive director of the company's inaugural board at the annual general meeting.
Dr. Huang's term will be effective from June 15, 2026, and will continue until the conclusion of the first board's term.
In a separate election held at the company's staff congress on the same date, Mr. Xu Feihu was elected as the employee representative director for the inaugural board.
Mr. Xu's tenure will also last until the first board's term expires.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.